News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
U.S. FDA Clears Dendreon Corporation’s Prostate Cancer Vaccine
April 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Dendreon Corp won U.S. approval on Thursday to sell a vaccine to treat men with advanced prostate cancer and the company's shares soared 15 percent.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Rare diseases
FDA Unwraps ‘Plausible Mechanism Pathway’ for Personalized Therapies
November 13, 2025
·
3 min read
·
Tristan Manalac
Job Trends
When, Not If: Job Market Should Start Turning Around in Next Year or So, Experts Say
November 13, 2025
·
6 min read
·
Angela Gabriel
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Podcast
Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers
November 12, 2025
·
1 min read
·
Heather McKenzie
